Reuters logo
BRIEF-Cellectis Announces the Issuance of US Patent 9,458,439
October 5, 2016 / 6:06 AM / a year ago

BRIEF-Cellectis Announces the Issuance of US Patent 9,458,439

Oct 5 (Reuters) - Cellectis SA :

* Announced on Tuesday the issuance of U.S. patent 9,458,439 - which claims gene inactivation by use of chimeric restriction endonucleases

* This patent granted by the USPTO to the Institut Pasteur and Boston Children’s Hospital naming Dr Andre Choulika and Pr. Richard C. Mulligan as co-inventors, is exclusively licensed to Cellectis

Source text for Eikon: Further company coverage:

Gdynia Newsroom

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below